2 recruiting, 1 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 2, Completed 1, Terminated 1 |
Follow Focal Onset Seizure: new trials by email Literature Review of Focal Onset Seizure trials Research Report on Focal Onset Seizure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures RAP-219 - Focal Epilepsy, Epilepsy | Phase 2 | Recruiting | Rapport Therapeutics Inc. | 30 | 2025-12-15 | 2026-01-23 |
| An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures 30mg PRAX-628 - Focal Onset Seizure, Primary Generalized Epilepsy | Phase 2 | Recruiting | Praxis Precision Medicines | 50 | 2025-01-10 | 2025-04-03 |
| Extension Study to Evaluate the Safety and Tolerability of NBI-921352 When Used With Anti-seizure Medications in Adults With Focal Onset Seizures NBI-921352 - Focal Onset Seizure, Focal Onset Epilepsy | Phase 2 | Terminated | Neurocrine Biosciences | 82 | 2022-11-09 | 2024-04-12 |
| A Study to Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures NBI-921352, Placebo - Focal Onset Seizure, Focal Onset Epilepsy | Phase 2 | Completed | Neurocrine Biosciences | 101 | 2021-11-08 | 2024-09-26 |
Seizures (4) · Epilepsy (3) · Epilepsies, Partial (1) · Epilepsy, Idiopathic Generalized (1)
Nervous System Diseases (4) · Neurologic Manifestations (4) · Pathological Conditions, Signs and Symptoms (4) · Signs and Symptoms (4) · Brain Diseases (3) · Central Nervous System Diseases (3)
Neurocrine Biosciences (2) · Praxis Precision Medicines (1) · Rapport Therapeutics Inc. (1)
Australia (3) · Spain (3) · Belgium (2) · Czechia (2) · France (2) · Hungary (2) · Italy (2) · United States (2)